137 related articles for article (PubMed ID: 17062732)
1. Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein.
Vlasáková J; Nováková Z; Rossmeislová L; Kahle M; Hozák P; Hodny Z
Blood; 2007 Feb; 109(4):1373-80. PubMed ID: 17062732
[TBL] [Abstract][Full Text] [Related]
2. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
Kim YE; Ahn JH
PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
[TBL] [Abstract][Full Text] [Related]
3. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
[TBL] [Abstract][Full Text] [Related]
4. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.
Kepkay R; Attwood KM; Ziv Y; Shiloh Y; Dellaire G
Cell Cycle; 2011 Jan; 10(2):308-22. PubMed ID: 21228624
[TBL] [Abstract][Full Text] [Related]
5. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Heuser M; van der Kuip H; Falini B; Peschel C; Huber C; Fischer T
Mediators Inflamm; 1998; 7(5):319-25. PubMed ID: 9883966
[TBL] [Abstract][Full Text] [Related]
6. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).
Grötzinger T; Sternsdorf T; Jensen K; Will H
Eur J Biochem; 1996 Jun; 238(2):554-60. PubMed ID: 8681971
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis.
Hsu KS; Zhao X; Cheng X; Guan D; Mahabeleshwar GH; Liu Y; Borden E; Jain MK; Kao HY
J Biol Chem; 2017 Jun; 292(24):10048-10060. PubMed ID: 28432122
[TBL] [Abstract][Full Text] [Related]
9. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
10. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.
Wu WS; Vallian S; Seto E; Yang WM; Edmondson D; Roth S; Chang KS
Mol Cell Biol; 2001 Apr; 21(7):2259-68. PubMed ID: 11259576
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
12. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
13. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
14. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis.
Hayakawa F; Abe A; Kitabayashi I; Pandolfi PP; Naoe T
J Biol Chem; 2008 Sep; 283(36):24420-5. PubMed ID: 18621739
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
Chung YL; Tsai TY
Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
[TBL] [Abstract][Full Text] [Related]
17. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.
Porta C; Hadj-Slimane R; Nejmeddine M; Pampin M; Tovey MG; Espert L; Alvarez S; Chelbi-Alix MK
Oncogene; 2005 Jan; 24(4):605-15. PubMed ID: 15580300
[TBL] [Abstract][Full Text] [Related]
18. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
19. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
20. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]